MedPage Today (7/28, DePeau-Wilson) reported, “Remotely administered urine drug screening was found to be feasible in patients with opioid use disorder (OUD) who were receiving buprenorphine in remote care settings,” investigators concluded.
Psychiatric News (7/28) reported, “Urine drug screening of people in treatment for” OUD “is feasible and reliable via telehealth,” investigators concluded in the findings of a 3,395-adult study published online July 28 in JAMA Health Forum.
Related Links:
— MedPage Today (requires login and subscription)